The S-1 effectiveness signals that OBX's IPO is imminent — likely pricing within 1-2 trading days. Traders should watch for the final prospectus (424B4) which will disclose the offering price and share count. Given the $1.2B pre-IPO market cap, this is a large biotech IPO; expect significant volatility in the first few days of trading. Monitor for any lockup expiration dates post-IPO.
Price Chart
Executive Summary
Obsidian Therapeutics' S-1 registration statement was declared effective by the SEC on September 9, 2026, clearing the way for the company to proceed with its initial public offering. The effectiveness typically precedes pricing by 1-2 days, meaning OBX shares could begin trading on Nasdaq imminently. This is a transformative event for the pre-revenue biotech, unlocking public market access and providing a new equity currency for pipeline development, though the exact offering size and price remain undisclosed in this filing.
Key Facts
- SEC declared Obsidian Therapeutics' S-1 registration (File No. 333-298642) effective on September 9, 2026.
- The S-1 was filed under the 1933 Securities Act, covering the company's initial public offering.
- Effectiveness typically precedes IPO pricing by 1-2 days, suggesting imminent trading on Nasdaq under ticker OBX.
- The company has a $1.2B market cap at the time of this filing, indicating strong pre-IPO demand.
- Obsidian Therapeutics is a clinical-stage pharmaceutical company (SIC 2834) focused on pharmaceutical preparations.
Financial Impact
IPO proceeds — amount undisclosed in this filing; market cap of $1.2B suggests a significant offering size relative to typical biotech IPOs.
Risk Factors
- IPO pricing may disappoint relative to the $1.2B market cap if market conditions deteriorate.
- Pre-revenue biotech with no approved products — clinical trial risk is high post-IPO.
- Dilution from the offering will impact existing shareholders.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (OBX) — Batch item 1 | 9999999995-26-002925 |
| Document: 9999999995-26-002925-index.html | 9999999995-26-002925 |
| Document: 9999999995-26-002925.txt | 9999999995-26-002925 |
| EFFECT Filing (OBX) — Batch item 4 | 9999999995-26-002925 |
| Document: 9999999995-26-002925-index.html | 9999999995-26-002925 |
| Document: 9999999995-26-002925.txt | 9999999995-26-002925 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 22d ago | SC 13G | $13.22 | awaiting T+20 | — | $14.25 (+7.79%) |
Sep 10, 2026 6w ago | EFFECT | $17.16 $12.24 | ▼ −28.67% | ▼ −30.80% | $14.25 (−16.96%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $14.25 (−58.09%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $14.25 (−58.09%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $14.25 (−58.09%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $14.25 (−58.09%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $14.25 (−58.09%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $14.25 (−58.09%) |
Aug 3, 2026 12w ago | 8-K | $34.00 $17.04 | ▲ +49.88% | ▲ +48.64% | $14.25 (+58.09%) |
Jul 6, 2026 16w ago | EFFECT | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers